- Home
- IRON vs WSC Comparison
IRON vs WSC Comparison
Compare IRON & WSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- WSC
- Stock Information
- Founded
- IRON 2017
- WSC 1944
- Country
- IRON United States
- WSC United States
- Employees
- IRON N/A
- WSC N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- WSC Misc Corporate Leasing Services
- Sector
- IRON Health Care
- WSC Industrials
- Exchange
- IRON Nasdaq
- WSC Nasdaq
- Market Cap
- IRON 3.4B
- WSC 3.8B
- IPO Year
- IRON N/A
- WSC N/A
- Fundamental
- Price
- IRON $89.84
- WSC $16.33
- Analyst Decision
- IRON Strong Buy
- WSC Buy
- Analyst Count
- IRON 12
- WSC 8
- Target Price
- IRON $108.83
- WSC $26.43
- AVG Volume (30 Days)
- IRON 531.4K
- WSC 3.4M
- Earning Date
- IRON 11-06-2025
- WSC 11-06-2025
- Dividend Yield
- IRON N/A
- WSC 1.72%
- EPS Growth
- IRON N/A
- WSC 816.06
- EPS
- IRON N/A
- WSC 1.20
- Revenue
- IRON N/A
- WSC $2,317,990,000.00
- Revenue This Year
- IRON N/A
- WSC N/A
- Revenue Next Year
- IRON N/A
- WSC $2.83
- P/E Ratio
- IRON N/A
- WSC $13.55
- Revenue Growth
- IRON N/A
- WSC N/A
- 52 Week Low
- IRON $30.82
- WSC $16.20
- 52 Week High
- IRON $95.95
- WSC $39.81
- Technical
- Relative Strength Index (RSI)
- IRON 64.84
- WSC 22.41
- Support Level
- IRON $83.00
- WSC $16.55
- Resistance Level
- IRON $90.39
- WSC $23.07
- Average True Range (ATR)
- IRON 3.70
- WSC 1.04
- MACD
- IRON -0.40
- WSC -0.40
- Stochastic Oscillator
- IRON 74.77
- WSC 1.10
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About WSC WillScot Mobile Mini Holdings Corp.
WillScot Holdings Corp designs, delivers, and services onsite, on-demand space solutions for clients. The company offers turnkey solutions in construction, education, manufacturing, retail, healthcare, and entertainment sectors. The products of the company includes modular office complexes, mobile offices, portable storage containers, and others.